Pharma Focus Asia

Almac Group Invests US$ 84.7 million (£80 million) to Open Manufacturing Facility in Ireland

Introduction:
The Almac Group plans to invest US$ 84.7 million (£80 million) in building new extensive manufacturing, production, and diagnostic laboratory facilities in Craigavon, Northern Ireland.  

Features:
The first of these two major projects is a state-of-the-art multi-product Good Manufacturing Practise (GMP) facility covering an impressive 100,000 square feet. 

This Centre of Excellence for manufacturing will house various essential components, including a custom-designed dispensary area, multiple production suites, process equipment wash facilities, and a lineside warehouse for storage at different temperature levels (ambient, refrigerated, and frozen). 

The primary focus of this new facility will be to support the production of solid oral dose products, complementing Almac's existing capabilities in this area.

The facility's expansion will not only increase existing manufacturing capabilities but also offer additional capacity to accommodate more strategic production contracts. 

The second project is a four- storey diagnostic development and manufacturing centre, spanning 40,000 square feet.

The new facility will empower to broaden its assay development capabilities and to manufacture and distribute companion diagnostic (CDx) kits on a commercial scale. 

The construction of these two substantial facilities will create over 550 job opportunities, encompassing a variety of roles, both in laboratory and non-laboratory positions. 

The facilities are projected to become operational by the third quarter of 2024.

Specifications:
Name        Almac Group
Type         New Construction
Budget    US$ 84.7 million (£80 million)
Year         2024


 

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference